期刊文献+

尼可地尔对异丙肾上腺素致心肌肥厚大鼠心肌MMP-9及TIMP-1表达的影响 被引量:1

Effect of nicorandil on MMP-9 and TIMP-1 expression in myocardium of a rat model of myocardial hypertrophy induced by isoprenaline
下载PDF
导出
摘要 目的探讨尼可地尔对异丙肾上腺素(ISO)所致心肌肥厚大鼠心肌基质金属蛋白酶9(MMP-9)和金属蛋白酶组织抑制因子1(TIMP-1)表达的影响。方法采用皮下注射ISO制备心肌肥厚模型。30只SD大鼠随机均分为对照组、模型组和尼可地尔组。测定心脏质量指数(HMI)和左心室质量指数(LVMI),酶联免疫吸附法测血浆中脑钠肽(BNP)含量,免疫组化法测定心肌组织MMP-9和TIMP-1表达。结果与对照组相比,模型组HMI、LVMI、BNP水平、MMP-9表达均明显增加(P<0.05),TIMP-1表达降低(P<0.05)。与模型组相比,尼可地尔组HMI、LVMI、BNP水平、MMP-9表达均明显降低(P<0.05),TIMP-1表达增加(P<0.05)。结论 ISO诱导心肌肥厚,MMPs/TIMPs系统平衡被破坏。尼可地尔可通过调节心肌组织MMP-9/TIMP-1的表达来逆转细胞外基质(ECM)重塑,从而预防心肌肥厚的发生。 Objective To investigate the effect of nicorandil on matrix metalloproteinases-9 (MMP-9) and tissue in- hibitors of metalloproteinases-1 ( TIMP-1 ) expression in myocardium of a rat model of myocardial hypertrophy in- duced by isoprenaline(ISO). Methods Myocardial hypertrophy model was established using subcutaneous injec- tion of ISO. 30 SD rats were randomized into control group, model group and nicorandil group. Heart mass index (HMI) and left ventricular mass index (LVMI) were calculated. The serum level of brain natriuretic peptide (BNP) was measured by enzyme-linked immunosorbent assay. Myocardium MMP-9 and TIMP-1 expression was an- alyzed by immunohistochemistry. Results Comparing with the control group, HMI, LVMI, BNP and the expres- sion of MMP-9 in model group significantly increased (P 〈 0.05 ) , and the expression of TIMP-1 significantly de- creased(P 〈 0. 05). In nicorandil group, comparing with the model group, HMI, LVMI, BNP and the expression of MMP-9 significantly decreased ( P 〈 0. 05 ) , and the expression of TIMP-1 was significantly increased ( P 〈 0. 05 ). Conclusion There is a destructive unbalance in the MMPs/TIMPs system in rat myocardial hypertrophy in- duced by ISO. Nicorandil could reverse extracellular matrix (ECM) remodeling and prevent cardiac hypertrophy, which is associated with the regulation of myocardium MMP-9 and TIMP-1 expression.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第8期903-906,共4页 Acta Universitatis Medicinalis Anhui
关键词 尼可地尔 心肌肥厚 基质金属蛋白酶9 金属蛋白酶组织抑制因子1 nicorandil myocardial hypertrophy MMP-9 TIMP-1
  • 相关文献

参考文献11

  • 1刘军锋,贾克刚,刘运德.基质金属蛋白酶与心脏重构及心肌病理损害的研究进展[J].中华老年心脑血管病杂志,2007,9(7):499-500. 被引量:12
  • 2Horinaka S, Yabe A,Yagi H, et al. Effects of nicorandil on cardi- ovascular events in the Japanese Coronary Artery Disease (JCAD) study[J]. Circ J, 2010, 74(3) :503 -9.
  • 3Lee T M, Lin M S, Chang N C. Effect of ATP-Sensitive potassium channel agonists on ventrieular remodeling in healed rat infarcts [J]. J Am Coll Cardiol, 2008, 51(13) :1309 -18.
  • 4Tang Y Q, Wang M H, Le X Y, et al. Antioxidant and cardiopro- tective effects of Danshensu ( 3- ( 3,4 -dihydroxyphenyl) -2 -hydroxy- propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats [ J ]. Phytomedicine, 2011, 18 (12) :1024 -30.
  • 5司延斌,龚培力,曾繁典.尼可地尔对心肌肥厚大鼠的保护作用及机制研究[J].中国药师,2006,9(4):301-304. 被引量:3
  • 6Ennis I L, Escudero E M, Console G M, et al. Regression of iso- proterenol-induced cardiac hypertrophy by Na^+/H^+ exchanger in- hibition[J]. Hypertension, 2003, 41(6) : 1324 -9.
  • 7Rolddn V, Marin F, Gimeno J R, et al. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy [ J ]. Am Heart J, 2008,156:85 - 91.
  • 8陈峰,王爱玲,徐凤,周美玲.尼可地尔对大鼠心肌缺血再灌注损伤的保护作用研究[J].安徽医科大学学报,2011,46(9):923-925. 被引量:8
  • 9Sakata Y, Nakatani D, Shimizu M, et al. Oral treatment with nic- orandil at discharge is associated with reduced mortality after acute myocardial infarction [ J]. J Cardiol, 2012, 59 : 14 - 21.
  • 10Yoo B S, Lee S H, Kim J Y, et al. BNP level as a useful predic- tive marker for LV remodeling after AMI[J]. J Card Fail, 2003, 9 (5) Suppl : s100.

二级参考文献28

  • 1朱慧,张薇,郭辰虹,张供,张维东,钟明,杨贵荣,葛志明,张运.心房肌基质金属蛋白酶-9和组织金属蛋白酶抑制因子-1表达改变对房颤心房重构机制的研究[J].中华医学杂志,2005,85(1):45-48. 被引量:30
  • 2柯丹,许春萱,林亚洲,张建成,陈林,林立芳,胡锡衷.心房颤动患者心房纤维化分子基础的临床研究[J].中华心血管病杂志,2005,33(5):459-463. 被引量:25
  • 3郭建中,高长青.基质金属蛋白酶在大鼠心肌梗死模型心室重塑中的作用[J].临床心血管病杂志,2005,21(6):364-366. 被引量:7
  • 4Simon S,Charles H,Maythem S.Long-term oral treatment with nicorandil prevents the progression of left ventricular hypertrophy and preserves viability[J].J Cardiovas Phar,2005,45 (4):333-340
  • 5Klein I.Thyroxine-induced cardiac hypertrophy:time course of development and inhibition by propranolol[J].Endocrinology,1988,123(1):203-2106.
  • 6Sato T,Sasaki O,Rourke B,et al.A potent cardioprotective agent acts by opening mitochondrial ATP-dependent potassium channels[J].JAm Coll Cardiol,2000,35:514-518
  • 7Wiley SR,Schooley K,Smolak P,et al.Identification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity,1995,3 (6):673-682
  • 8Messeli FH,Ketelhut R.Left ventricular hypertrophy:an independent risk factor[J].J Cardiovasc Phar,1991,17(sup 4):S59-S67
  • 9Markham A,Plosker GL,Goa KL.Nicorandil,an updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects[J].Drugs,2000,60:955-974
  • 10Lee RT,Lammerding J.Signaling pathways that influence extracellular remodeling[J].J Card Fail,2002,8:339-343.

共引文献20

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部